title: [Cardiac scintigraphy-Pharmacological stress and appropriate management of pediatric radiopharmaceutical administration in patients after Kawasaki disease].
abstract: Cardiac scintigraphy accounted for 2.5 % of all 3,884 patients based on a survey ques- tionnaire of pediatric nuclear medicine examinations performed at 14 Japanese institutes in 2011. Myocardial perfusion imaging, classified as cardiac scintigraphy, is essential to detect myocardial ischemia in patients after Kawasaki disease (KD), although its less frequent performance is reported. Adenosine is widely noticed as a medication for pharma- cological stress testing in coronary arterial lesions after KD. We describe characteristics of adenosine including newly-devised administration protocol and pathway making of intravenous injection for stress testing. We comment on optimal radiopharmaceutical administered doses proposed in Japanese consensus guidelines for pediatric nuclear medi- cine. Their proposal doses approximate that calculated by Pediatric Dosage Card of Euro- pean Association of Nuclear Medicine. We hope myocardial perfusion imaging is performed under appropriate management of pediatric radiopharmaceutical administration.
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Kamiyama
authors.forename: Kensuke
authors.initials: K
authors.lastname: Karasawa
mesh_terms: D002648:Child; D006321:Heart / Q000187:drug effects*; D006801:Humans; D009080:Mucocutaneous Lymph Node Syndrome / Q000139:chemically induced / Q000000981:diagnostic imaging*; D055414:Myocardial Perfusion Imaging / Q000295:instrumentation / Q000379:methods*; D017410:Practice Guidelines as Topic; D011859:Radiography; D019275:Radiopharmaceuticals / Q000009:adverse effects / Q000494:pharmacology*; D013312:Stress, Physiological
chemical_list: D019275:Radiopharmaceuticals